June 11, 2019  HOUSTON–(BUSINESS WIRE)–InGeneron, Inc., a clinical stage regenerative medicine and cell therapy company, announced today the extension of its Series D financing by up to $23 million, totaling up to $43 million to be invested in the organization. The additional funds will come from InGeneron’s clinical partner Sanford Health, one of the largest …